Literature DB >> 19906945

Analysis of latent viral gene expression in natural and experimental latency models of human cytomegalovirus and its correlation with histone modifications at a latent promoter.

Matthew B Reeves1, John H Sinclair.   

Abstract

Human cytomegalovirus (HCMV) is an opportunistic human pathogen that establishes a lifelong latent infection, which can reactivate periodically. If unchecked by a robust immune response, this reactivation can result in severe disease in immunocompromised patients. Reactivation of latent virus in myeloid progenitor cells is concomitant with cellular differentiation through regulation of the major immediate-early promoter (MIEP) by chromatin remodelling. In this study, we analysed the expression of the latent gene transcript UL81-82as (LUNA). LUNA is expressed in latently infected CD34(+) cells and its expression decreases as CD34(+) cells differentiate to immature dendritic cells. Upon maturation (and HCMV reactivation), a second wave of transcription occurs, consistent with expression during lytic infection. Furthermore, we show that the LUNA promoter is associated with acetylated histones during HCMV latency in experimentally and naturally infected CD34(+) cells, thus suggesting that latent gene promoters are, like the MIEP, regulated by post-translational modifications of their associated histone proteins.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19906945     DOI: 10.1099/vir.0.015602-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  75 in total

1.  Transient CD8-memory contraction: a potential contributor to latent cytomegalovirus reactivation.

Authors:  Jonathan Campbell; Joanne Trgovcich; Michelle Kincaid; Peter D Zimmerman; Paul Klenerman; Stuart Sims; Charles H Cook
Journal:  J Leukoc Biol       Date:  2012-06-22       Impact factor: 4.962

2.  Cellular and viral control over the initial events of human cytomegalovirus experimental latency in CD34+ cells.

Authors:  Ryan T Saffert; Rhiannon R Penkert; Robert F Kalejta
Journal:  J Virol       Date:  2010-03-24       Impact factor: 5.103

Review 3.  Chromatin-mediated regulation of cytomegalovirus gene expression.

Authors:  Matthew B Reeves
Journal:  Virus Res       Date:  2010-09-25       Impact factor: 3.303

4.  Maintenance of large numbers of virus genomes in human cytomegalovirus-infected T98G glioblastoma cells.

Authors:  Ying-Liang Duan; Han-Qing Ye; Anamaria G Zavala; Cui-Qing Yang; Ling-Feng Miao; Bi-Shi Fu; Keun Seok Seo; Christian Davrinche; Min-Hua Luo; Elizabeth A Fortunato
Journal:  J Virol       Date:  2014-01-22       Impact factor: 5.103

Review 5.  Herpesvirus latency.

Authors:  Jeffrey I Cohen
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

6.  Mechanisms modulating immune clearance during human cytomegalovirus latency.

Authors:  Barry Slobedman; Edward S Mocarski
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-04       Impact factor: 11.205

7.  Human Cytomegalovirus Enters the Primary CD34+ Hematopoietic Progenitor Cells Where It Establishes Latency by Macropinocytosis.

Authors:  Jeong-Hee Lee; Robert F Kalejta
Journal:  J Virol       Date:  2019-07-17       Impact factor: 5.103

8.  Canonical and Variant Forms of Histone H3 Are Deposited onto the Human Cytomegalovirus Genome during Lytic and Latent Infections.

Authors:  Emily R Albright; Robert F Kalejta
Journal:  J Virol       Date:  2016-10-28       Impact factor: 5.103

9.  Dynamics of Human Cytomegalovirus Infection in CD34+ Hematopoietic Cells and Derived Langerhans-Type Dendritic Cells.

Authors:  Roxanne Coronel; Sachiko Takayama; Timothy Juwono; Laura Hertel
Journal:  J Virol       Date:  2015-03-11       Impact factor: 5.103

10.  Public and private human T-cell clones respond differentially to HCMV antigen when boosted by CD3 copotentiation.

Authors:  Laura R E Becher; Wendy K Nevala; Shari Lee Sutor; Megan Abergel; Michele M Hoffmann; Christopher A Parks; Larry R Pease; Adam G Schrum; Svetomir N Markovic; Diana Gil
Journal:  Blood Adv       Date:  2020-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.